Document and Entity Information
Document and Entity Information | May 31, 2023 |
Entity Addresses [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 31, 2023 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 001-39990 |
Entity Registrant Name | Elicio Therapeutics, Inc. |
Entity Central Index Key | 0001601485 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 11-3430072 |
Entity Address, Address Line One | 451 D Street |
Entity Address, Address Line Two | 5th Floor |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02210 |
City Area Code | 857 |
Local Phone Number | 209-0050 |
Title of 12(b) Security | Common Stock, $0.01 par value per share |
Trading Symbol | ELTX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Information, Former Legal or Registered Name | Angion Biomedica Corp. |
Former Address [Member] | |
Entity Addresses [Line Items] | |
Entity Address, Address Line One | 7-57 Wells Avenue |
Entity Address, City or Town | Newton |
Entity Address, State or Province | MA |
Entity Address, Country | US |
Entity Address, Postal Zip Code | 02459 |